---
figid: PMC3701121__nihms484395f3
figtitle: Angiogenesis signaling pathways in epilepsy
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3701121
filename: nihms484395f3.jpg
figlink: /pmc/articles/PMC3701121/figure/F3/
number: F3
caption: 'Angiogenesis signaling pathways in epilepsy. Proposed vascular endothelial
  growth factor (VEGF) pro-angiogenic pathways: (i) Inositol trisphosphate (IP3),
  endothelial nitric oxide synthase (eNOS), and phospholipase C (PLC) induce the proteolysis
  of the basement membrane by MMP-2 and MMP-9. (ii) PLC and P42/44-MAP kinase promote
  endothelial cells (EC) proliferation and migration. (iii) Src, PI3K, and p38MAP
  kinase degrade the tight junctions. VEGF neuroprotective pathways: (i): Local perfusion
  is improved by PKC-mediated ECs proliferation, whereas eNOS affords a rapid adaptation
  of local blood flow to neuron energetic demand. (ii) VEGFR-2 expressed by neurons
  provides an autocrine protection via the anti-apoptotic PI3K pathway. Angiopoietins
  effects: Ang1, released by pericytes is a constitutive ligand of Tie2, enabling
  cell maturation and protections via PI3-K/Akt. On the contrary, the inducible Ang2,
  released by endothelial Weibel–Palade bodies, acts as a Tie2 antagonist worsening
  VEGF effects on the vasculature. The ratio Ang1/Ang2 has an impact on vascular permeability.'
papertitle: Cerebrovascular Remodeling and Epilepsy.
reftext: Nicola Marchi, et al. Neuroscientist. ;19(3):304-312.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9271383
figid_alias: PMC3701121__F3
figtype: Figure
redirect_from: /figures/PMC3701121__F3
ndex: 031fd23a-df0c-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3701121__nihms484395f3.html
  '@type': Dataset
  description: 'Angiogenesis signaling pathways in epilepsy. Proposed vascular endothelial
    growth factor (VEGF) pro-angiogenic pathways: (i) Inositol trisphosphate (IP3),
    endothelial nitric oxide synthase (eNOS), and phospholipase C (PLC) induce the
    proteolysis of the basement membrane by MMP-2 and MMP-9. (ii) PLC and P42/44-MAP
    kinase promote endothelial cells (EC) proliferation and migration. (iii) Src,
    PI3K, and p38MAP kinase degrade the tight junctions. VEGF neuroprotective pathways:
    (i): Local perfusion is improved by PKC-mediated ECs proliferation, whereas eNOS
    affords a rapid adaptation of local blood flow to neuron energetic demand. (ii)
    VEGFR-2 expressed by neurons provides an autocrine protection via the anti-apoptotic
    PI3K pathway. Angiopoietins effects: Ang1, released by pericytes is a constitutive
    ligand of Tie2, enabling cell maturation and protections via PI3-K/Akt. On the
    contrary, the inducible Ang2, released by endothelial Weibel–Palade bodies, acts
    as a Tie2 antagonist worsening VEGF effects on the vasculature. The ratio Ang1/Ang2
    has an impact on vascular permeability.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - TM7SF2
  - ANGPT2
  - VPS51
  - VEGFA
  - TEK
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - KDR
  - TIE1
  - AKT1
  - AKT2
  - AKT3
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - SRC
  - FGR
  - FYN
  - YES1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - CUX1
  - CYTIP
  - CRTAP
  - CASP9
  - NOS3
  - ENO4
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - Cancer
  - Cardiomyopathy
---
